Abstract
The TOR (target of rapamycin) proteins play important roles in nutrient signaling in eukaryotic cells. Rapamycin treatment induces a state reminiscent of the nutrient starvation response, often resulting in growth inhibition. Using a chemical genetic modifier screen, we identified two classes of small molecules, small-molecule inhibitors of rapamycin (SMIRs) and small-molecule enhancers of rapamycin (SMERs), that suppress and augment, respectively, rapamycin's effect in the yeast Saccharomyces cerevisiae. Probing proteome chips with biotinylated SMIRs revealed putative intracellular target proteins, including Tep1p, a homolog of the mammalian PTEN (phosphatase and tensin homologue deleted on chromosome 10) tumor suppressor, and Ybr077cp (Nir1p), a protein of previously unknown function that we show to be a component of the TOR signaling network. Both SMIR target proteins are associated with PI(3,4)P2, suggesting a mechanism of regulation of the TOR pathway involving phosphatidylinositides. Our results illustrate the combined use of chemical genetics and proteomics in biological discovery and map a path for creating useful therapeutics for treating human diseases involving the TOR pathway, such as diabetes and cancer.
MeSH Terms
Humans
Jurkat Cells
Models, Biological
Protein Array Analysis
Protein Kinases/genetics,metabolism
Proteomics
Saccharomyces cerevisiae/drug effects,genetics,metabolism
Saccharomyces cerevisiae Proteins/genetics,metabolism
Signal Transduction
Sirolimus/pharmacology
TOR Serine-Threonine Kinases
Chemicals
Saccharomyces cerevisiae Proteins
Protein Kinases
MTOR protein, human
TOR Serine-Threonine Kinases
Sirolimus
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Huang Jing
Howard Hughes Medical Institute, Harvard Institute of Chemistry and Cell Biology, and Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA.
[email protected]
Zhu Heng
Haggarty Stephen J
Spring David R
Hwang Heejun
Jin Fulai
Snyder Michael
Schreiber Stuart L
References (32)
32 references, click to expand
-
The TOR signaling cascade regulates gene expression in response to nutrients.
Genes Dev. 1999 Dec 15;13(24):3271-9
PMID: 10617575
-
A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy.
Science. 1999 Sep 10;285(5434):1733-7
PMID: 10481009
-
A chemical switch for inhibitor-sensitive alleles of any protein kinase.
Nature. 2000 Sep 21;407(6802):395-401
PMID: 11014197
-
Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen.
Science. 1999 Oct 29;286(5441):971-4
PMID: 10542155
-
From molecular to modular cell biology.
Nature. 1999 Dec 2;402(6761 Suppl):C47-52
PMID: 10591225
-
The TOR signalling pathway controls nuclear localization of nutrient-regulated transcription factors.
Nature. 1999 Dec 9;402(6762):689-92
PMID: 10604478
-
Rapamycin-modulated transcription defines the subset of nutrient-sensitive signaling pathways directly controlled by the Tor proteins.
Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):14866-70
PMID: 10611304
-
TEP1, the yeast homolog of the human tumor suppressor gene PTEN/MMAC1/TEP1, is linked to the phosphatidylinositol pathway and plays a role in the developmental process of sporulation.
Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12672-7
PMID: 11070083
-
Integrated genomic and proteomic analyses of a systematically perturbed metabolic network.
Science. 2001 May 4;292(5518):929-34
PMID: 11340206
-
An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice.
Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10320-5
PMID: 11504907
-
Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.
Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10314-9
PMID: 11504908
-
Linking molecular therapeutics to molecular diagnostics: inhibition of the FRAP/RAFT/TOR component of the PI3K pathway preferentially blocks PTEN mutant cells in vitro and in vivo.
Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10031-3
PMID: 11526226
-
Global analysis of protein activities using proteome chips.
Science. 2001 Sep 14;293(5537):2101-5
PMID: 11474067
-
Rapamycin's resurrection: a new way to target the cancer cell cycle.
J Natl Cancer Inst. 2001 Oct 17;93(20):1517-9
PMID: 11604470
-
Mechanisms of resistance to rapamycins.
Drug Resist Updat. 2001 Dec;4(6):378-91
PMID: 12030785
-
The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation.
Mol Cell Biol. 2002 Aug;22(15):5575-84
PMID: 12101249
-
Functional profiling of the Saccharomyces cerevisiae genome.
Nature. 2002 Jul 25;418(6896):387-91
PMID: 12140549
-
Transcriptional regulatory networks in Saccharomyces cerevisiae.
Science. 2002 Oct 25;298(5594):799-804
PMID: 12399584
-
Tor signalling in bugs, brain and brawn.
Nat Rev Mol Cell Biol. 2003 Feb;4(2):117-26
PMID: 12563289
-
Protein analysis on a proteomic scale.
Nature. 2003 Mar 13;422(6928):208-15
PMID: 12634794
-
Raptor and mTOR: subunits of a nutrient-sensitive complex.
Curr Top Microbiol Immunol. 2004;279:259-70
PMID: 14560962
-
Proteomics: where's Waldo in yeast?
Nature. 2003 Oct 16;425(6959):671-2
PMID: 14562083
-
Activation of the RAS/cyclic AMP pathway suppresses a TOR deficiency in yeast.
Mol Cell Biol. 2004 Jan;24(1):338-51
PMID: 14673167
-
Glucose induces cAMP-independent growth-related changes in stationary-phase cells of Saccharomyces cerevisiae.
Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5724-8
PMID: 1648229
-
Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast.
Science. 1991 Aug 23;253(5022):905-9
PMID: 1715094
-
PIK-related kinases: DNA repair, recombination, and cell cycle checkpoints.
Science. 1995 Oct 6;270(5233):50-1
PMID: 7569949
-
Exploring the metabolic and genetic control of gene expression on a genomic scale.
Science. 1997 Oct 24;278(5338):680-6
PMID: 9381177
-
TOR signalling and control of cell growth.
Curr Opin Cell Biol. 1997 Dec;9(6):782-7
PMID: 9425342
-
Cell wall integrity modulates RHO1 activity via the exchange factor ROM2.
EMBO J. 1998 Apr 15;17(8):2235-45
PMID: 9545237
-
The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.
J Biol Chem. 1998 May 29;273(22):13375-8
PMID: 9593664
-
The lipid phosphatase activity of PTEN is critical for its tumor supressor function.
Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13513-8
PMID: 9811831
-
Functional discovery via a compendium of expression profiles.
Cell. 2000 Jul 7;102(1):109-26
PMID: 10929718